SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lotus Eye Hospital And Institute informs about final dividend

23 Sep 2022 Evaluate

Lotus Eye Hospital And Institute has informed that the Final dividend recommended by the Board of Directors in its meeting held on 25.05.2022 has been approved by the Shareholders in the 25th Annual General meeting held on Thursday 22nd September 2022. The Final Dividend shall be disbursed within 30 days of the Annual General Meeting to all those shareholders whose name appears in the Register of Beneficial owners maintained by CDSL and NSDL as on 10th September 2022.

The above information is a part of company’s filings submitted to BSE.

Lotus Eye Hospital Share Price

111.00 -1.50 (-1.33%)
21-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×